Allstate Analyst Price Targets - Benzinga

Allstate Corp

ALLNYSE

Trade with Public

Trade with Public

$250.20

-1.51-0.6%

마지막 업데이트: Oct 28, 5:56 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 주식 보고서

© 2026 Benzinga | All Rights Reserved

Allstate Analyst Price Targets

Wall Street analyst price targets and consensus rating for Allstate (ALL).

Price Target Range — 9 Quarters

Analyst Consensus — 22 Analysts

1S.Buy

10Buy

8Hold

3Sell

Consensus RatingBuy# Analysts22Avg. Consensus PT$261Upside to Avg. PT+5.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	Wells Fargo	Elyse Greenspan	Upgrade	Underweight→Equal-Weight	$250→$236
Oct 12, 2026	Keefe, Bruyette & Woods	Meyer Shields	PT Cut	Underperform	$250→$232
Oct 7, 2026	Mizuho	Yaron Kinar	PT Cut	Outperform	$300→$295
Oct 7, 2026	Barclays	Alex Scott	PT Cut	Underweight	$226→$221
Oct 6, 2026	Morgan Stanley	Bob Huang	PT Cut	Equal-Weight	$265→$240
Oct 2, 2026	Citigroup	Matthew Heimermann	PT Cut	Sell	$240→$215
Oct 1, 2026	Goldman Sachs	Robert Cox	PT Cut	Neutral	$280→$250
Sep 18, 2026	Mizuho	Yaron Kinar	PT Raise	Outperform	$297→$300
Sep 16, 2026	Mizuho	Yaron Kinar	PT Cut	Outperform	$300→$297
Aug 28, 2026	Argus Research	Kevin Heal	Downgrade	Buy→Hold	—
Aug 20, 2026	Keefe, Bruyette & Woods	Meyer Shields	Downgrade	Market Perform→Underperform	$255→$250
Aug 13, 2026	BMO Capital	Michael Zaremski	PT Raise	Buy	$250→$284
Aug 11, 2026	Mizuho	Yaron Kinar	PT Raise	Outperform	$272→$300
Aug 11, 2026	Citigroup	Matthew Heimermann	Downgrade	Neutral→Sell	$226→$240
Aug 11, 2026	JP Morgan	Pablo Singzon	PT Raise	Overweight	$282→$292
Aug 10, 2026	Goldman Sachs	Robert Cox	PT Raise	Neutral	$250→$280
Aug 10, 2026	UBS	Brian Meredith	PT Raise	Neutral	$261→$275
Aug 10, 2026	Piper Sandler	Paul Newsome	PT Raise	Overweight	$268→$300
Aug 7, 2026	Freedom Broker	Mikhail Paramonov	Upgrade	Hold→Buy	$297
Aug 7, 2026	Wells Fargo	Elyse Greenspan	Downgrade	Equal-Weight→Underweight	$243→$250

Analyst Ratings News

Travelers Companies Is Likely ‘Overearning,’ Says Bearish Analyst

Bank of America says Travelers is “overearning,” citing declining policies, slowing underwriting profits and a rich valuation.

Priya Nigam

PRO
Wells Fargo Upgrades Allstate to Equal-Weight, Lowers Price Target to $236

Wells Fargo analyst Elyse Greenspan upgrades Allstate (NYSE:ALL) from Underweight to Equal-Weight and lowers the price target from $250 to $236.

Benzinga Newsdesk

PRO
Keefe, Bruyette & Woods Maintains Underperform on Allstate, Lowers Price Target to $232

Keefe, Bruyette & Woods analyst Meyer Shields maintains Allstate (NYSE:ALL) with a Underperform and lowers the price target from $250 to $232.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Allstate, Lowers Price Target to $295

Mizuho analyst Yaron Kinar maintains Allstate (NYSE:ALL) with a Outperform and lowers the price target from $300 to $295.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Allstate, Lowers Price Target to $221

Barclays analyst Alex Scott maintains Allstate (NYSE:ALL) with a Underweight and lowers the price target from $226 to $221.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Allstate, Lowers Price Target to $240

Morgan Stanley analyst Bob Huang maintains Allstate (NYSE:ALL) with a Equal-Weight and lowers the price target from $265 to $240.

Benzinga Newsdesk